Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome

Xuguang Zhang1, Zhiwei Huang2, Xin Wang1

  • 1Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China.

Insights

Platelet morphological parameters like MPV, PDW, and P-LCR are elevated in acute coronary syndrome (ACS) patients. These markers predict coronary severity and adverse outcomes, with combined assessment improving risk stratification.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarker Discovery

Background:

  • Platelet activation is key in acute coronary syndrome (ACS) pathogenesis.
  • Platelet morphological parameters, including mean platelet volume (MPV), platelet distribution width (PDW), and platelet-large cell ratio (P-LCR), are emerging as significant biomarkers.
  • These parameters show potential in predicting ACS severity and patient prognosis.

Purpose of the Study:

  • To investigate the relationship between MPV, PDW, and P-LCR and the severity of coronary artery lesions in ACS patients.
  • To evaluate the predictive value of these platelet parameters for adverse clinical outcomes.
  • To assess the diagnostic performance of these parameters in ACS.

Main Methods:

  • A prospective observational study involving 134 ACS patients and 50 healthy controls.
  • Measurement of MPV, PDW, and P-LCR at admission.
  • Coronary artery lesion severity assessed using the Gensini score via coronary angiography.
  • Multivariate logistic regression and ROC curve analysis to determine predictive and diagnostic values.

Main Results:

  • ACS patients exhibited significantly higher MPV, PDW, and P-LCR compared to controls (p < 0.001).
  • Strong positive correlations were observed between these platelet parameters and the Gensini score (r = 0.778–0.800; p < 0.001).
  • MPV, PDW, and P-LCR were identified as independent predictors of adverse prognosis (p < 0.001).
  • Combined assessment of MPV, PDW, and P-LCR demonstrated superior predictive accuracy (AUC = 0.927).

Conclusions:

  • Elevated platelet morphological parameters are strongly linked to coronary artery lesion severity in ACS.
  • These parameters serve as independent predictors of adverse outcomes in ACS patients.
  • The combined evaluation of MPV, PDW, and P-LCR offers enhanced risk stratification, aiding therapeutic guidance and prognosis improvement.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
464
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.1K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
970